|
Name |
beta-Cedrene
|
Molecular Formula | C15H24 | |
IUPAC Name* |
(1S,2R,5S,7S)-2,6,6-trimethyl-8-methylidenetricyclo[5.3.1.01,5]undecane
|
|
SMILES |
C[C@@H]1CC[C@@H]2[C@]13CCC(=C)[C@H](C3)C2(C)C
|
|
InChI |
InChI=1S/C15H24/c1-10-7-8-15-9-12(10)14(3,4)13(15)6-5-11(15)2/h11-13H,1,5-9H2,2-4H3/t11-,12+,13+,15+/m1/s1
|
|
InChIKey |
DYLPEFGBWGEFBB-OSFYFWSMSA-N
|
|
Synonyms |
beta-Cedrene; 546-28-1; (+)-beta-Cedrene; .beta.-Cedrene; (+)-.beta.-Cedrene; 6QL7ERD5Q1; 1H-3a,7-Methanoazulene, octahydro-3,8,8-trimethyl-6-methylene-, (3R,3aS,7S,8aS)-; (+)-beta-Funebrene; Cedr-8(15)-ene; (1S,2R,5S,7S)-2,6,6-trimethyl-8-methylidenetricyclo[5.3.1.01,5]undecane; (3R,3aS,7S,8aS)-3,8,8-Trimethyl-6-methyleneoctahydro-1H-3a,7-methanoazulene; 1H-3a,7-Methanoazulene,octahydro-3,8,8-trimethyl-6-methylene-,(3R,3aS,7S,8aS)-; 1H-3a,7-Methanoazulene, octahydro-3,8,8-trimethyl-6-methylene-, [3R-(3.alpha.,3a.beta.,7.beta.,8a.alpha.)]-; 1H-3A,7-METHANOAZULENE, OCTAHYDRO-3,8,8-TRIMETHYL-6-METHYLENE-, (3R-(3.ALPHA.,3A.BETA.,7.BETA.,8A.ALPHA.))-; EINECS 208-898-8; (+)- beta -Cedrene; UNII-6QL7ERD5Q1; DTXSID40883435; MFCD00270433; ZINC59778864; AKOS015896901; 1H-3a,7-Methanoazulene, octahydro-3,8,8-trimethyl-6-methylene-, (3R-(3alpha,3abeta,7beta,8aalpha))-; (+)-beta-Cedrene, >=95.0% (sum of enantiomers, GC); (3R-(3alpha,3Abeta,7beta,8aalpha))-octahydro-3,8,8-trimethyl-6-methylene-1H-3a,7-methanoazulene
|
|
CAS | 546-28-1 | |
PubChem CID | 11106485 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 204.35 | ALogp: | 4.9 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 15 | QED Weighted: | 0.491 |
Caco-2 Permeability: | -4.573 | MDCK Permeability: | 0.00001850 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.923 |
30% Bioavailability (F30%): | 0.864 |
Blood-Brain-Barrier Penetration (BBB): | 0.228 | Plasma Protein Binding (PPB): | 82.71% |
Volume Distribution (VD): | 0.809 | Fu: | 16.80% |
CYP1A2-inhibitor: | 0.372 | CYP1A2-substrate: | 0.299 |
CYP2C19-inhibitor: | 0.254 | CYP2C19-substrate: | 0.851 |
CYP2C9-inhibitor: | 0.334 | CYP2C9-substrate: | 0.265 |
CYP2D6-inhibitor: | 0.054 | CYP2D6-substrate: | 0.691 |
CYP3A4-inhibitor: | 0.263 | CYP3A4-substrate: | 0.26 |
Clearance (CL): | 13.3 | Half-life (T1/2): | 0.061 |
hERG Blockers: | 0.021 | Human Hepatotoxicity (H-HT): | 0.244 |
Drug-inuced Liver Injury (DILI): | 0.234 | AMES Toxicity: | 0.007 |
Rat Oral Acute Toxicity: | 0.715 | Maximum Recommended Daily Dose: | 0.956 |
Skin Sensitization: | 0.124 | Carcinogencity: | 0.472 |
Eye Corrosion: | 0.92 | Eye Irritation: | 0.925 |
Respiratory Toxicity: | 0.953 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003109 | 1.000 | D04VIS | 0.267 | ||||
ENC003097 | 0.673 | D0D2VS | 0.259 | ||||
ENC001831 | 0.577 | D04SFH | 0.253 | ||||
ENC002998 | 0.577 | D0H1QY | 0.250 | ||||
ENC001893 | 0.527 | D0L2LS | 0.247 | ||||
ENC001172 | 0.474 | D0Z1XD | 0.244 | ||||
ENC003477 | 0.474 | D0I2SD | 0.239 | ||||
ENC003096 | 0.474 | D0V8HA | 0.237 | ||||
ENC003215 | 0.464 | D0F1UL | 0.235 | ||||
ENC002267 | 0.458 | D0G8BV | 0.235 |